WO2015029539A1 - 微生物検出方法 - Google Patents
微生物検出方法 Download PDFInfo
- Publication number
- WO2015029539A1 WO2015029539A1 PCT/JP2014/065313 JP2014065313W WO2015029539A1 WO 2015029539 A1 WO2015029539 A1 WO 2015029539A1 JP 2014065313 W JP2014065313 W JP 2014065313W WO 2015029539 A1 WO2015029539 A1 WO 2015029539A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- test
- meth
- sample solution
- medium
- synthetic adsorbent
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/22—Testing for sterility conditions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/405—Concentrating samples by adsorption or absorption
Definitions
- the present invention relates to a microorganism detection method, and more particularly to a microorganism detection method capable of reducing the influence of an antibacterial substance contained in a test sample and detecting a target microorganism with high accuracy.
- microbial inspections of products and raw materials are conducted to ensure quality and safety.
- test method official methods are defined in each field, and various microbial test methods are listed in the Japanese Pharmacopoeia for pharmaceutical products.
- the microbial limit test method is prescribed, and this includes a viable count test for measuring the viable count and a specific microbial test for specific pathogenic microorganisms.
- the general test method 5.02 defines the microbial limit test method for crude drugs in the crude drug test method.
- herbal medicines which are the raw materials of Kampo medicines, contain a wide variety of compounds ranging from low molecules to high molecules, and many of these compounds are characteristic components (terpenoids, alkaloids, flavonoids, quinones, amino acids). , Fatty acids, saccharides, etc.) and contains many antibacterial substances (terpenoids, alkaloids, flavonoids, tannins, etc.).
- Kampo extract preparations consist of several kinds of herbal medicines, they contain a wide range of antibacterial substances.
- the Kampo extract preparation contains many insoluble fine particles derived from its production method, and membrane filtration which is widely used for removing antibacterial substances cannot be used.
- the dilution rate is increased or the culture medium is increased, the sensitivity decreases, so it cannot be said that the method should be preferentially selected.
- Patent Document 1 a method for removing antibacterial substances in a test sample by adding activated carbon and acidic clay or activated clay to the medium.
- This method is useful in specific microorganism tests, but in the viable count test by the Kanteng plate pour method using agar medium, the medium is colored by activated carbon and the transparency of the medium is increased by acid clay or activated clay. It is difficult to identify the village because it falls. Furthermore, since these substances are not easy to separate and remove, there is a problem that it is difficult to accurately identify and measure the settlement.
- a microorganism detection method capable of effectively reducing the influence and detecting the target microorganism with high accuracy is desired, and an object of the present invention is to provide such a microorganism detection method.
- the present inventors can adsorb and remove a wide range of antibacterial substances contained in a test sample, Adsorption action is weak for nutrients necessary for the growth of microorganisms, so that the growth of target microorganisms is not hindered and detection accuracy can be improved, and even if the adsorbent is added, the medium does not color Since it can be easily removed after the action, it has been found that accurate measurement is possible even by the Kanteng flat plate mixing method, and the present invention has been completed.
- the present invention includes a step of preparing a sample solution containing a test sample having antibacterial activity and a step of culturing a target microorganism in a culture medium, and (meth) acrylate synthetic adsorption on the sample solution and / or culture medium It is a method for detecting microorganisms in a test sample having antibacterial activity, characterized by allowing an agent to act.
- the microorganism detection method of the present invention effectively adsorbs and removes the antibacterial substance contained in the test sample, so that the growth of the target microorganism is not inhibited during culture, and this can be detected accurately and accurately. Is possible.
- the range of microorganisms to be detected is wide, and the application target is wide and versatile, such as being applicable to many Chinese herbal extracts and herbal medicines.
- the (meth) acrylic ester synthetic adsorbent used in the present invention does not cause the medium to become colored or opaque even when added to the medium, and is easy to separate and remove after acting. Villages can be accurately identified by the flat plate mixing method, and can be measured quickly and accurately.
- Example 6 it is the graph which plotted the addition collection
- Example 6 it is the graph which plotted the addition collection
- the method of the present invention is a method for detecting a microorganism in a test sample having antibacterial activity, and this method includes a step of preparing a sample solution containing the test sample and a step of culturing the target microorganism in a culture medium.
- this method is characterized in that a (meth) acrylate synthetic adsorbent is allowed to act on either or both of the sample solution in the sample solution preparation step and the culture medium in the culture step.
- test samples having antibacterial activity examples include Kampo extract preparations and herbal medicines.
- the Kampo extract preparation is obtained by formulating an extract component obtained by extracting a Kampo prescription using water, a water-soluble solvent such as ethanol, and its dosage form is not particularly limited, and is a powder, granule, tablet, Any of liquids, pills, capsules and the like may be used.
- Kampo medicines have been developed in Japan, with the ratios and indications (symptoms) of herbal medicines described in medical books written in ancient China originally developed in Japan. The blending ratio is determined.
- Kampo prescriptions include kakon-yu, kakane-yu Kagawa cucumber, otoji-yu, annaka-san, ten-mi-futou, hachimi-jio-maru, daisai-ko-yu, sho-saiko-yu, saiko-kueda-yu, shiba Kokei-do Qinyu-yu, Saiko-ka Ryu-bone oyster hot-spring, Hanka-shinshin-yu, Huangren detoxification hot-water, Semi-summer Kobok-yu, Gojosan, Keishi-ka-ka-so-yu, Shosei-ryu-yu, Ho-so-Kao-yu Kayu-yu, Shofu-san, Toki Shaku-Yaku-san, Kami-san, Katsushido Karasuma, Katsue-ka-ryu oyster bath, Mao-yu,
- herbal medicines are processed parts of medicinal parts of animals and plants, cell contents, secretions, extracts or minerals such as washing, peeling, cutting, drying and sorting.
- Specific examples include: Aji, Asen Yaku, Anise, Wei Sensen, Jin Chin, Horny Sheep, Mutsu, Yakuyaku, Yong Hang, Jasmine, Huang Gon, Jasam, Cherry Bark, Huang Ren, Longish, Guy Leaf, Lyrics, What's ⁇ , Kasone, Talc, Catch, Chamomile, Karo Root, Karou Jin, Inui, Licorice, Kikyo, Kakimi, Chrysanthemum, Valerian Root, Sakai, Apricot Jin, Golden Silver Flower, Zushi, Ginseng, ⁇ , Cinnamon bark, decision maker, genno shoko, koi, safflower, katsukiko, glutinous rice, magnolia, beef yellow, ox knees, gyudon, beef coconut, sesame seeds,
- test sample solution containing the above test sample.
- the test sample is a liquid, it can be used as a sample solution as it is.
- the sample solution is prepared by suspending in an appropriate diluent after pulverization, crushing, grinding, etc., as necessary.
- an appropriate diluent such as Japanese Pharmacopoeia (refer to 16th revision, General Test Method 4.05, Microbial Limit Test Method and 5.02, Microbial Limit Test Method of Crude Drugs, the same shall apply hereinafter)
- a buffer solution such as a buffer solution or a liquid medium is preferably used.
- liquid medium examples include soy bean / casein / digest medium (hereinafter abbreviated as SCD medium), Sabouraud liquid medium, and the like.
- SCD medium soy bean / casein / digest medium
- Sabouraud liquid medium examples include soy bean / casein / digest medium (hereinafter abbreviated as SCD medium), Sabouraud liquid medium, and the like.
- the dilution rate is preferably 10 to 1000 times, more preferably 10 to 60 times, further preferably 10 to 30 times, and particularly preferably 10 to 20 times from the viewpoint of measurement sensitivity and accuracy.
- the sample liquid prepared as described above is added to the culture medium and the target microorganism is cultured.
- a liquid medium such as SCD medium
- it can be cultured as it is as a culture medium without being added to the culture medium.
- the culture medium is not particularly limited.
- a medium listed in the Japanese Pharmacopoeia can be appropriately selected according to the type of microorganism to be detected, and specifically, a soy bean / casein / digest agar medium ( Hereinafter, abbreviated as SCDA medium), lecithin / polysorbate 80 added soybean / casein / digest agar medium (hereinafter abbreviated as SCDLPA medium), Sabouraud / glucose agar medium (hereinafter abbreviated as SDA medium), potato / dextrose agar medium (hereinafter abbreviated as “SDA medium”). , Abbreviated as PDA medium), glucose-peptone agar medium (hereinafter abbreviated as GPA medium), and the like.
- the culture conditions are appropriately set according to the type of the target microorganism, but may be set according to, for example, the microbial limit test method of the Japanese Pharmacopoeia.
- a (meth) acrylate synthetic adsorbent is allowed to act on the sample solution and / or culture medium.
- “(meth) acrylic acid” means acrylic acid and / or methacrylic acid.
- the (meth) acrylic ester adsorbent is not particularly limited, but the most frequent radius (when dried) of the pores is preferably 50 to 1000 mm, more preferably 50 to 500 mm.
- the specific surface area is preferably 100 to 700, more preferably 130 to 570 (m 2 / g), and the pore volume is preferably 0.4 to 1.5, more preferably 0.5 to 1. 3 (ml / g).
- Such a range is preferable because it is excellent in the action of selectively adsorbing an antibacterial substance and has a high effect of suppressing the growth inhibition of microorganisms.
- the method for allowing the (meth) acrylate synthetic adsorbent to act on the sample solution and / or the culture medium is not particularly limited, and the sample solution and / or culture medium is synthesized using the (meth) acrylate ester synthesis. What is necessary is just to contact an adsorbent.
- a (meth) acrylic ester synthetic adsorbent may be added to the sample solution prepared as described above. Specifically, a (meth) acrylate synthetic adsorbent is added to the diluted solution together with the test sample, or the test sample is added to a diluted solution to which the (meth) acrylate synthetic adsorbent has been added in advance.
- a (meth) acrylic ester synthetic adsorbent may be contained in the sample solution.
- the antibacterial substance eluted from the test sample is adsorbed on the (meth) acrylate synthetic adsorbent. Removed. Further, the antibacterial substance can be adsorbed and removed more efficiently by stirring and mixing the test sample and the sample solution containing the (meth) acrylic ester synthetic adsorbent for a predetermined time.
- the stirring and mixing time is not particularly limited, but for example, stirring and mixing may be performed for about 10 to 60 minutes.
- the content of the (meth) acrylate synthetic adsorbent in the sample solution is preferably 3 to 20% by mass, and more preferably 5 to 10% by mass. Within this range, good detection accuracy can be obtained, and the pipette handling property is not affected.
- the (meth) acrylic ester synthetic adsorbent may remain in the sample liquid as it is. It can also be separated and removed from.
- the separation / removal method is not particularly limited, and may be separated by a known solid-liquid separation means using a sieve, filter paper, or the like.
- the antibacterial activity in the test sample is sufficiently reduced by allowing the (meth) acrylate synthetic adsorbent to act on the sample solution in this way, the adsorbent is removed from the sample solution, Even if it is cultured without adding the adsorbent, the target microorganism shows good growth and high detection accuracy can be obtained.
- a (meth) acrylate synthetic adsorbent can also be allowed to act on the culture medium. If the adsorbent is not removed from the sample solution, this is directly used as the culture medium. What is necessary is just to add and when removing, the said adsorption agent should just be separately added in a culture medium.
- the antibacterial substance in the culture medium can be adsorbed and removed.
- the content of the (meth) acrylic ester synthetic adsorbent in the culture medium is preferably 3 to 20% by mass, more preferably 5 to 10% by mass. Within this range, high detection accuracy can be obtained.
- the adsorbent may be allowed to act only on the culture medium without allowing the (meth) acrylate synthetic adsorbent to act on the sample solution.
- the method for causing the adsorbent to act and the amount added in the culture medium are the same as described above.
- the medium was not colored and maintained transparency, so it was formed after the culture. It is possible to accurately identify the settlement. Furthermore, when the (meth) acrylic ester synthetic adsorbent is separated and removed from the sample solution and then added to the culture medium and cultured, the colonies can be more accurately identified. It is possible to measure villages accurately and quickly.
- the (meth) acrylate synthetic adsorbent used in the present invention exhibits an adsorption action on a wide range of antibacterial substances and has a weak adsorption action on nutrient components necessary for the growth of microorganisms.
- the method can be applied to a wide range of test samples and microorganisms.
- the (meth) acrylic ester synthetic adsorbent does not affect the medium such as coloring, and can be easily separated and removed, so the test method is not limited.
- the method of the present invention is, for example, a test for the number of viable bacteria such as the total number of aerobic microorganisms and the total number of fungi specified in the microbial limit test method listed in the Japanese Pharmacopoeia, bile acid resistant gram-negative bacteria, Escherichia coli, Pseudomonas aeruginosa, etc. It can be applied to specific microorganism tests such as fungi, Salmonella, Staphylococcus aureus, Clostridia, Candida albicans.
- Reference example 1 Preparation of fungal suspension: According to the 16th revision Japanese Pharmacopoeia General Test Method 4.05 Microbial Limit Test Method, a bacterial solution for inoculation to be used for the microbial test was prepared. (Test strain) E.
- coli Esscherichia coli, hereinafter referred to as ECO
- SAU Staphylococcus aureus
- PAE Pseudomonas aeruginosa
- BSU Bacillus subtilis
- CAL Candida albicans
- ABR Aspergillus brasiliensis
- CSP Clostridium sporogenes
- a suspension was obtained.
- BSU prepared a spore suspension by heat-treating the culture solution to kill vegetative cells.
- ABR was cultured in PDA medium at 20 to 25 ° C. When good sporulation was observed, the obtained spores were scraped to prepare a spore solution. (Preparation of bacterial solution for inoculation) These bacterial suspensions were serially diluted with a peptone salt buffer or the like to prepare a bacterial solution for inoculation.
- Example 1 Examination of adsorbent (1) 10 g of a sample (Daiseikito extract granule; manufactured by Tsumura Co., Ltd.) was weighed and added to 90 mL of a peptone salt buffer solution (prepared in a 200 mL Erlenmeyer flask) to which 10% by mass of an adsorbent had been added. was prepared.
- adsorbent Diaion (registered trademark) HP20 (styrene), Diaion (registered trademark) HP2MG (methacrylic), Sepabeads (registered trademark) SP700 (styrene), Sepabeads (registered trademark) SP207 (styrene) Used (all manufactured by Mitsubishi Chemical Corporation).
- Example 2 Examination of adsorbent (2) 10 g of a sample (Daisenkito extract granule; manufactured by Tsumura Co., Ltd.) was weighed, and 90 mL of SCD medium (200 mL Erlenmeyer flask) with adsorbent (HP20, HP2MG) added to 3, 5, 10 mass%. The sample solution was prepared by stirring. These sample solutions were collected and passed through a sieve to obtain a 10-fold diluted sample solution. 10 mL of this 10-fold diluted sample solution was dispensed into test tubes.
- the bacterial solution for inoculation of SAU prepared according to Reference Example 1 was added so as to be 100 CFU / mL or less, allowed to stand for 1 hour, dispensed into a petri dish, and mixed with SCDA medium. After culturing within 30 days at 30 to 35 ° C., settlement measurement was performed. The recovery rate was calculated in the same manner as in Example 1 to determine suitability.
- the synthetic adsorbent may be difficult to handle in dispensing into a petri dish (pipette operation), the difficulty is evaluated according to the following criteria. The results are shown in Table 2.
- HP2MG showed a good recovery rate at any content. On the other hand, with HP20, 10% by mass showed a good recovery rate, but 5% by mass or less was insufficient. Also, HP2MG had good handling properties even at 10%, but HP20 was difficult to pipette even at 3% by mass.
- Example 3 Addition recovery test (1): 10 g of a Chinese herbal extract preparation that has been confirmed to have high antibacterial activity (Sho Seiryu, Jun-to, Daikokanzo-to, Daijoki-to; manufactured by Tsumura Co., Ltd., all extract granules) A sample solution was prepared by adding to 90 mL of 10 mass% HP2MG-added SCD medium (prepared in a 200 mL Erlenmeyer flask) and stirring. This sample solution was collected and passed through a sieve to obtain a 10-fold diluted sample solution. 10 mL of this 10-fold diluted sample solution was dispensed into test tubes.
- Each Kampo extract preparation was subjected to a viable cell count test and an E. coli test according to the microbial limit test method of the 16th revised Japanese Pharmacopoeia General Test Method 4.05.
- 10 g of each sample was weighed, added to 90 mL of SCD medium (prepared in a 200 mL Erlenmeyer flask) containing 10% by mass of the adsorbent shown in Table 4, and stirred for 30 minutes to prepare a sample solution did. These sample solutions were collected and passed through a sieve to obtain a 10-fold diluted sample solution.
- the extract powder As for the extract powder, 5 g of each sample was weighed, and a 20-fold diluted sample solution was prepared in the same manner except that it was added to 95 mL of SCD medium added with 10% by mass of the adsorbent shown in Table 4. (Viable count test) The BSU or SAU inoculum prepared in Reference Example 1 was added to the prepared sample solution so that the number of inoculated bacteria was 100 CFU or less and stirred. The sample solution after stirring was filtered, and the filtrate was dispensed into a petri dish and mixed with SCDA medium. Culture was performed within 30 days at 30 to 35 ° C., and BSU or SAU colony measurement was performed. The recovery rate was calculated in the same manner as in Example 1.
- Example 5 Viable count test (Kanten plate pour method): The Kampo extract granule 128 formulation (all manufactured by Tsumura Corporation) shown in Table 5 below was subjected to a viable cell count test using SAU, PAE, BSU, CAL, and ABR as test bacteria.
- SAU total aerobic bacterial count
- TYMC total fungal count
- SAU total aerobic bacterial count
- SAU total fungal count
- SCD medium prepared in a 200 mL Erlenmeyer flask
- sample solutions were collected and passed through a sieve to obtain a 10-fold diluted sample solution.
- 10 mL of this 10-fold diluted sample solution was dispensed into test tubes.
- Each bacterial solution for inoculation prepared in Reference Example 1 was added to 100 CFU / mL or less and allowed to stand for 1 hour. (TAMC measurement)
- TAMC measurement After inoculating the inoculated 10-fold diluted sample solution, 1 mL was dispensed into a petri dish and mixed with SCDA medium.
- the culture conditions were colony measurement within 5 days at 30 to 35 ° C., and the recovery rate was calculated in the same manner as in Example 1.
- the recovery rate was less than 50% in only one test plot, confirming that the method was very versatile.
- the recovery rate can be increased to 50% or more by a slight modification of the test method.
- Example 6 Addition recovery test (2): The influence of the dilution factor on the recovery rate was confirmed. 5 g of Kampo extract powder (Daikankanzo-to, Daijoki-to, both manufactured by Tsumura Co., Ltd.), which has been confirmed to have antibacterial activity against BSU, is added to 95 mL of SCD medium or 10% by mass HP2MG. In addition to 95 mL of SCD medium (prepared in a 200 mL Erlenmeyer flask), the mixture was stirred to obtain a sample solution having a dilution factor of 20 times.
- Kampo extract powder Daikankanzo-to, Daijoki-to, both manufactured by Tsumura Co., Ltd.
- SCD medium prepared in a 200 mL Erlenmeyer flask
- the Kampo extract powder was added to an SCD medium or an SCD medium supplemented with 10% by mass of HP2MG at a dilution of 30, 50, and 100 times, and stirred to obtain sample solutions with a dilution ratio of 30, 50, and 100 times.
- the bacterial solution for inoculation of BSU prepared in Reference Example 1 was added to each test group at dilution ratios of 20, 30, 50, and 100 times so that the number of inoculated bacteria was 100 CFU / mL or less, and allowed to stand for 1 hour. Thereafter, the sample solution prepared in HPDB with added SCDB was passed through a sieve, and each sample solution was dispensed into a petri dish and mixed with SCDA medium.
- the sample solution prepared in SCD medium without adding HP2MG could not recover 50% or more of BSU unless diluted to 50 to 100 times, but in 10% HP2MG-added SCD medium, the recovery rate was 50% or more when diluted 20 times. was gotten. Therefore, the viable count test for BSU of Daikokanzoto extract and Daijokito extract can be performed at a dilution ratio of 30 times or less, preferably at a dilution ratio of 20 to 30 times by adding 10 mass% HP2MG. It turned out that.
- Example 7 Addition recovery test (3): 11 herbal extract powders that have been confirmed to have antibacterial activity against BSU Weigh 5 g of hot water, bamboo jo hot boiled water, yellow ream hot water, Asako Jinmaru, Daijoki-to (both manufactured by Tsumura Co., Ltd.), 95 mL of SCD medium or 95 mL of SCD medium with 10% by mass HP2MG (200 mL volume) Prepared in an Erlenmeyer flask) and stirred to prepare a sample solution. The sample solution was collected and passed through a sieve to obtain 20-fold diluted sample solutions.
- the inoculum of BSU prepared in Reference Example 1 was added so that the number of inoculated bacteria was 100 CFU / mL or less, allowed to stand for 1 hour, and then dispensed into a petri dish, using SCDA medium. Poured. After culturing at 30 to 35 ° C. within 5 days, colony measurement was performed, and the recovery rate was calculated in the same manner as in Example 1. If the recovery rate was 50% or more, it was judged as conforming: ⁇ , and if it was less than 50%, it was judged as nonconforming: x. The results are shown in Table 10.
- the recovery rate of BSU was less than 50% in any prescription, but the recovery rate of 50% or more was obtained in all SCD media with 10% HP2MG. Therefore, live bacteria against BSU of semi-summer Koboku hot water, ginseng hot water, semi-summer Hakuho Tenma-yu, Momonuclear Kiyu-to, Gonjo-joki-yu, Hiragasaku, Takejo hot-boiled hot water, Koren-yu and Asakojinmaru extract powder It was found that several tests can be carried out at a dilution factor of 20 by adding 10 mass% HP2MG.
- Example 8 Specific microorganism test (E. coli): (Direct culture method) Chinese herbal extract powders that have been confirmed to have antibacterial activity against E. coli (Otsuji-yu, Dai-saiko-to, Koshi-saiko-to, Kami-san, Jun-in-to, Momokure-joki-to, Shak-yaku-kanzo-to, Dai-ko-kanso Weighed 5 g of hot water, tsudensan, saba ⁇ yu, and chin chinyu (both manufactured by Tsumura Co., Ltd.) and weighed 95 mL of SCD medium or 95 mL of SCD medium with 10% by mass HP2MG (prepared in a 200 mL Erlenmeyer flask) And a sample solution diluted 20 times was prepared by stirring.
- E. coli Direct culture method Chinese herbal extract powders that have been confirmed to have antibacterial activity against E. coli (Otsuji-yu
- the ECO inoculum solution prepared in Reference Example 1 was added to the sample solution so that the number of inoculated bacteria was 50 CFU or less, and cultured at 30 to 35 ° C. for 24 hours. After culturing, the culture solution was smeared on a MacConky agar medium and cultured at 30 to 35 ° C. for 24 hours to confirm the growth of ECO. If ECO was growing, it was judged as conforming: +, and if it was not growing, it was judged as nonconforming:-. The results are shown in Table 11.
- a sample solution was prepared by diluting Daikokanzoto powder, in which growth of ECO was not observed by direct culture (20-fold dilution), in 10% HP2MG-added SCD medium. After adding ECO inoculum to the sample solution to 100 CFU or less, 20 mL of 20-fold diluted solution was dispensed into 40 mL of SCD medium to obtain a 60-fold diluted solution, and cultured at 30 to 35 ° C. for 24 hours. . After culturing, the culture solution was smeared on a MacConky agar medium and cultured at 30 to 35 ° C. for 24 hours to confirm the growth of ECO. If ECO was growing, it was judged as conforming: +, and if it was not growing, it was judged as nonconforming:-. The results are shown in Table 11.
- Example 9 Specific microorganism test (Clostridial): 10 g of Kampo Extract Granules (Maoh-to, Sakai Chinto, both manufactured by Tsumura Co., Ltd.) that have been confirmed to have antibacterial activity against Clostridia in 90 mL of SCD medium or 90 mL of 10% by mass HP2MG-added SCD medium. In addition, stirring was performed to prepare a 10-fold diluted sample solution.
- CSP bacterial solution (BioBall (registered trademark) MultiShot550 Clostridium sporogenes NCTC12935 manufactured by Sysmex Biomelieu) is added so that the number of inoculated bacteria is 50 CFU or less.
- the cells were cultured at 35 ° C. for 48 hours under anaerobic conditions.
- the culture solution was smeared on Colombian agar medium and cultured at 30 to 35 ° C. for 48 hours under anaerobic conditions to confirm the growth of CSP. If the CSP was growing, it was judged as conforming: +, and if it was not growing, it was judged as nonconforming:-. The results are shown in Table 12.
- Example 10 Specific microorganism test (E. coli): Weighing 5g of crude drug (Dai yellow), which has been confirmed to have antibacterial activity against E. coli, added to 95mL of SCD medium or 95mL of SCD medium with 10% by mass HP2MG (prepared in a 200mL Erlenmeyer flask) and stirred. Thus, a sample solution having a dilution factor of 20 was obtained. Similarly, herbal medicine (Daihuang) was added to SCD medium or 10% by mass HP2MG-added SCD medium at a dilution of 100 and 200 times and stirred to obtain a sample solution having a dilution ratio of 100 and 200 times.
- crude drug Dai yellow
- HP2MG prepared in a 200mL Erlenmeyer flask
- the ECO inoculum solution prepared in Reference Example 1 was added to each sample solution so that the number of inoculated bacteria was 50 CFU or less, and the cells were cultured at 30 to 35 ° C. for 24 hours. After culturing, the culture solution was smeared on a MacConky agar medium and cultured at 30 to 35 ° C. for 24 hours to confirm the growth of ECO. If ECO was growing, it was judged as conforming: +, and if it was not growing, it was judged as nonconforming:-. The results are shown in Table 13.
- the microorganism detection method of the present invention can detect microorganisms in a test sample with high accuracy by reducing the influence of various antibacterial substances. Therefore, it is extremely useful as a method for testing microorganisms of Kampo extract preparations and herbal medicines having antibacterial activity.
Abstract
Description
菌懸濁液の調製:
第16改正日本薬局方 一般試験法4.05 微生物限度試験法に準じて、微生物試験に使用する接種用菌液を調製した。
(試験菌株)
大腸菌(Escherichia coli,以下、ECOと略す):IFO No.3972
黄色ブドウ球菌(Staphylococcus aureus,以下、SAUと略す):IFO No.13276
緑膿菌(Pseudomonas aeruginosa,以下、PAEと略す):IFO No.13275
バチルス・サブチルス(Bacillus subtilis,以下、BSUと略す):IFO No.3134
カンジダ・アルビカンス(Candida albicans,以下、CALと略す):IFO No.1594
アスペルギルス・ブラジリエンシス(Aspergillus brasiliensis,以下、ABRと略す):NBRC No.9455
クロストリジア(Clostridium sporogenes, 以下、CSPと略す):NCTC No.12935
(菌懸濁液の調製)
100mL容の三角フラスコに入れたSCD培地50mLに斜面培地保存菌株を1エーゼ(白金耳)接種し、ECO、SAU、PAEは30~35℃で、CALは20~25℃で培養して、菌懸濁液とした。
BSUは培養菌液を加熱処理し、栄養細胞を殺滅して胞子懸濁液を調製した。
ABRはPDA培地で20~25℃で培養し、良好な胞子形成が認められたら、得られた胞子をかき取り、胞子液を調製した。
(接種用菌液の調製)
これらの菌懸濁液をペプトン食塩緩衝液等で段階希釈し、接種用菌液を調製した。
吸着剤の検討(1):
試料(大承気湯エキス顆粒;株式会社ツムラ製)10gを秤取し、10質量%吸着剤が添加されたペプトン食塩緩衝液90mL(200mL三角フラスコにて調製)に加え、攪拌し、試料液を調製した。吸着剤として、ダイヤイオン(登録商標)HP20(スチレン系)、ダイヤイオン(登録商標)HP2MG(メタクリル系)、セパビーズ(登録商標)SP700(スチレン系)、セパビーズ(登録商標)SP207(スチレン系)を使用した(いずれも三菱化学株式会社製)。また10質量%吸着剤に代えて、10質量%スキムミルクを用いて同様に調製した試料液、3質量%活性炭および5質量%活性白土を加えたSCD培地を用意した。各試料液を分取し、篩(ステンレス製)を通過させて10倍希釈試料液とした。この10倍希釈試料液を10mLずつ試験管に分取した。各試験管に、参考例1で調製したSAUの接種用菌液を100CFU/mL以下になるように添加し、2時間静置したのちにシャーレに分注し、SCDLPA培地(日本製薬株式会社製)にて混釈した。30~35℃、5日以内で培養後、集落測定を実施した。10倍希釈試料液にペプトン食塩緩衝液を添加したもの(ブランク)及びろ過した10質量%吸着剤加SCD培地10mLに上記と同様にして菌液を添加したもの(試料非添加区)についても同様に集落測定を行い、下記式より回収率を算出した。回収率が50%以上であれば適合:○、50%未満であれば不適合:×と判定した。
A:各試験区の集落数
B:ブランクの集落数
C:試料非添加区の集落数
吸着剤の検討(2):
試料(大承気湯エキス顆粒;株式会社ツムラ製)10gを秤取し、3、5、10質量%となるように吸着剤(HP20、HP2MG)を添加したSCD培地90mL(200mL容三角フラスコにて調製)に加え、攪拌し、試料液を調製した。これら試料液を分取し、篩を通過させて10倍希釈試料液とした。この10倍希釈試料液を10mLずつ試験管に分取した。各試験区に、参考例1により調製したSAUの接種用菌液を100CFU/mL以下になるように添加し、1時間静置したのちにシャーレに分注し、SCDA培地にて混釈した。30~35℃、5日以内で培養後、集落測定を実施した。実施例1と同様にして回収率を算出し、適合性を判定した。また合成吸着剤はシャーレへの分注(ピペット操作)においてハンドリングが困難になるケースがあるので、その難易について下記基準により評価した。結果を表2に示す。
○:一般的な滅菌メスピペットでの液体のハンドリング上問題ない。
×:秤取困難、均一に分取出来ない、つまる等の問題があるなど、ハンドリングに支障が出る。
添加回収試験(1):
抗菌活性が高いことが確認されている漢方エキス製剤(小青竜湯、潤腸湯、大黄甘草湯、大承気湯;株式会社ツムラ製、いずれもエキス顆粒)を10g秤取し、5、10質量%HP2MG加SCD培地90mL(200mL容三角フラスコにて調製)に加え、攪拌し、試料液を調製した。この試料液を分取し、篩を通過させて10倍希釈試料液とした。この10倍希釈試料液を10mLずつ試験管に分取した。各試験区に、参考例1で調製したBSU又はPAEの接種用菌液を、それぞれ100CFU/mL以下になるように添加し、1時間静置したのちにシャーレに分注し、SCDA培地にて混釈した。30~35℃、5日以内で培養後、集落測定を実施した。実施例1と同様にして回収率を算出した。回収率が50%以上であれば適合:○、50%未満であれば不適合:×と判定した。結果を表3に示す。
吸着剤の検討(3):
BSUに対して抗菌活性を示すことが確認されている潤腸湯のエキス粉末、二朮湯および大承気湯の漢方エキス顆粒(いずれも株式会社ツムラ製)およびSAUに対して抗菌活性を示すことが確認されている潤腸湯のエキス粉末および大承気湯の漢方エキス顆粒(いずれも株式会社ツムラ製)を生菌数試験の被験試料とした。また、ECOに対して抗菌活性を示すことが確認されている大柴胡湯、大黄甘草湯、通導散の漢方エキス粉末(いずれも株式会社ツムラ製)を大腸菌試験の被験試料とした。各漢方エキス製剤について、第16改正日本薬局方 一般試験法4.05の微生物限度試験法に準じ、生菌数試験及び大腸菌試験を行った。漢方エキス顆粒については、各試料10gを秤取し、表4に示す吸着剤を10質量%添加したSCD培地90mL(200mL容三角フラスコにて調製)に加え、30分間攪拌し、試料液を調製した。これら試料液を分取し、篩を通過させて10倍希釈の試料液とした。エキス粉末については、各試料5gを秤取し、表4に示す吸着剤を10質量%添加したSCD培地95mLに加えた以外は同様にして20倍希釈の試料液とした。
(生菌数試験)
調製した試料液に、参考例1で調製したBSUもしくはSAUの接種用菌液を接種菌数が100CFU以下になるように添加し、攪拌した。攪拌後の試料液をろ過し、ろ液をシャーレに分注して、SCDA培地にて混釈した。30~35℃、5日以内で培養し、BSUもしくはSAUの集落測定を実施した。実施例1と同様にして回収率を算出した。回収率が50%以上であれば適合:○、50%未満であれば不適合:×と判定した。
(大腸菌試験)
調製した試料液に、ECOの接種菌数が50CFU以下になるように添加し、30~35℃で24時間培養した。培養後、培養液をマッコンキーカンテン培地に塗抹し、30~35℃で24時間培養し、ECOの発育を確認した。ECOが発育していれば適合:+、発育していなければ不適合:-と判定した。これらの結果を表4に示す。
生菌数試験(カンテン平板混釈法):
下記表5に示す漢方エキス顆粒128処方(いずれも株式会社ツムラ製)について、SAU、PAE、BSU、CAL、ABRを供試菌として生菌数試験を行った。CAL、ABRについては、総好気性菌数(TAMC)測定及び総真菌数(TYMC)測定を行い、SAU、PAE、BSUについてはTAMC測定を行った。
各試料10gを秤取し、10質量%となるようにHP2MGを添加したSCD培地90mL(200mL容三角フラスコにて調製)に加え、攪拌し、試料液を調製した。これら試料液を分取し、篩を通過させて10倍希釈試料液とした。この10倍希釈試料液を10mLずつ試験管に分取した。参考例1で調製した各接種用菌液を、それぞれ100CFU/mL以下になるように添加し、1時間静置した。
(TAMC測定)
接種した10倍希釈試料液を攪拌した後、シャーレに1mL分注し、SCDA培地にて混釈した。培養条件は30~35℃にて5日以内で集落測定を実施し、実施例1と同様にして回収率を算出した。回収率が50%以上であれば適合:○、50%未満であれば不適合:×と判定した。
(TYMC測定)
接種した10倍希釈試料液を攪拌した後、シャーレに1mL分注し、SDA培地にて混釈した。培養条件は20~25℃にて5日以内で集落測定を実施し、実施例1と同様にして回収率を算出した。回収率が50%以上であれば適合:○、50%未満であれば不適合:×と判定した。結果を表5~8に示す。
なお、回収率が50%未満となった1試験区についても、多少の試験法の改変で回収率50%以上にすることが可能である。
添加回収試験(2):
希釈倍率の添加回収率に対する影響を確認した。BSUに対して抗菌性があることが確認されている漢方エキス粉末(大黄甘草湯、大承気湯;いずれも、株式会社ツムラ製)を5g秤取し、SCD培地95mLまたは10質量%HP2MG加SCD培地95mL(200mL容三角フラスコにて調製)に加え、攪拌して希釈倍率20倍試料液を得た。同様に、当該漢方エキス粉末をSCD培地または10質量%HP2MG加SCD培地に30、50、および100倍希釈になるように加え、攪拌して希釈倍率30、50、および100倍試料液を得た。希釈倍率20、30、50、100倍の各試験区に、参考例1で調製したBSUの接種用菌液を接種菌数が100CFU/mL以下になるように添加し、1時間静置した。その後、HP2MG加SCDBにて調製した試料液は篩を通過させて、各試料液をシャーレに分注し、SCDA培地にて混釈した。30~35℃、5日以内にて培養後、集落測定を行い、実施例1と同様にして回収率を算出した。回収率が50%以上であれば適合:○、50%未満であれば不適合:×と判定した。結果を表9と図1及び図2に示す。
添加回収試験(3):
BSUに対して抗菌性があることが確認されている漢方エキス粉末11処方(半夏厚朴湯、人参湯、半夏白朮天麻湯、桃核承気湯、調胃承気湯、平胃散、大黄甘草湯、竹ジョ温胆湯、黄連湯、麻子仁丸、大承気湯;いずれも、株式会社ツムラ製)を5g秤取し、SCD培地95mL又は10質量%HP2MG加SCD培地95mL(200mL容三角フラスコにて調製)に加え、攪拌し、試料液を調製した。試料液を分取し篩を通過させて、それぞれ20倍希釈試料液とした。各試験区に、参考例1で調製したBSUの接種用菌液を接種菌数が100CFU/mL以下になるように添加し、1時間静置したのちにシャーレに分注し、SCDA培地にて混釈した。30~35℃、5日以内にて培養後、集落測定を行い、実施例1と同様にして回収率を算出した。回収率が50%以上であれば適合:○、50%未満であれば不適合:×と判定した。結果を表10に示す。
特定微生物試験(大腸菌):
(直接培養法)
大腸菌に対して抗菌活性があることが確認されている漢方エキス粉末(乙字湯、大柴胡湯、 小柴胡湯、加味逍遙散、潤腸湯、桃核承気湯、シャク薬甘草湯、大黄甘草湯、通導散、柴苓湯、茵チン蒿湯;いずれも、株式会社ツムラ製)5gを秤取し、SCD培地95mL又は10質量%HP2MG加SCD培地95mL(200mL容三角フラスコにて調製)に加え、攪拌し、20倍希釈の試料液を調製した。試料液に参考例1で調製したECOの接種用菌液を接種菌数が50CFU以下になるように添加し、30~35℃で24時間培養した。培養後、培養液をマッコンキーカンテン培地に塗抹し、30~35℃で24時間培養し、ECOの発育を確認した。ECOが発育していれば適合:+、発育していなければ不適合:-と判定した。結果を表11に示す。
直接培養法(20倍希釈)でECOの発育が認められなかった大黄甘草湯エキス粉末を10%HP2MG加SCD培地にて20倍希釈の試料液を調製した。当該試料液にECOの接種菌数が100CFU以下になるように添加した後、20倍希釈液20mLを40mLのSCD培地に分注して60倍希釈液とし、30~35℃で24時間培養した。培養後、培養液をマッコンキーカンテン培地に塗抹し、30~35℃で24時間培養し、ECOの発育を確認した。ECOが発育していれば適合:+、発育していなければ不適合:-と判定した。結果を表11に示す。
特定微生物試験(クロストリジア):
クロストリジアに対して抗菌活性があることが確認されている漢方エキス顆粒(麻黄湯、茵チン蒿湯;いずれも、株式会社ツムラ製)10gを、SCD培地90mL又は10質量%HP2MG加SCD培地90mLに加えて攪拌し、10倍希釈の試料液を調製した。各試料液10mLを90mLの強化クロストリジア培地に接種したのちに、CSP菌液(シスメックスビオメリュー社製BioBall(登録商標)MultiShot550 Clostridium sporogenes NCTC12935)を接種菌数が50CFU以下になるように添加し、30~35℃で48時間嫌気的条件下培養した。培養後、培養液をコロンビアカンテン培地に塗抹し、30~35℃で48時間嫌気的条件下培養し、CSPの発育を確認した。CSPが発育していれば適合:+、発育していなければ不適合:-と判定した。結果を表12に示す。
特定微生物試験(大腸菌):
大腸菌に対して抗菌活性があることが確認されている生薬(大黄)を5g秤取し、SCD培地95mL又は10質量%HP2MG加SCD培地95mL(200mL容三角フラスコにて調製)に加え、攪拌して希釈倍率20倍試料液を得た。同様に、生薬(大黄)をSCD培地または10質量%HP2MG加SCD培地に100および200倍希釈になるように加え、攪拌して希釈倍率100、200倍試料液を得た。各試料液に参考例1で調製したECOの接種用菌液を接種菌数が50CFU以下になるように添加し、30~35℃で24時間培養した。培養後、培養液をマッコンキーカンテン培地に塗抹し、30~35℃で24時間培養し、ECOの発育を確認した。ECOが発育していれば適合:+、発育していなければ不適合:-と判定した。結果を表13に示す。
Claims (11)
- 抗菌活性を有する被験試料を含有する試料液を調製する工程及び対象微生物を培養培地で培養する工程を含み、試料液及び/又は培養培地に(メタ)アクリル酸エステル系合成吸着剤を作用させることを特徴とする抗菌活性を有する被験試料中の微生物検出方法。
- (メタ)アクリル酸エステル系合成吸着剤の細孔の最頻度(細孔)半径が50~1000Åである請求項1記載の微生物検出方法。
- 試料液に(メタ)アクリル酸エステル系合成吸着剤を作用させるものである請求項1又は2に記載の微生物検出方法。
- 試料液中に(メタ)アクリル酸エステル系合成吸着剤を添加するものである請求項3記載の微生物検出方法。
- 試料液中の(メタ)アクリル酸エステル系合成吸着剤の含有量が3~20質量%である請求項3又は4記載の微生物検出方法。
- 抗菌活性を有する被験試料及び(メタ)アクリル酸エステル系合成吸着剤を含有する試料液を所定時間撹拌混合するものである請求項3~5のいずれかの項記載の微生物検出方法。
- (メタ)アクリル酸エステル系合成吸着剤を試料液に作用させた後、(メタ)アクリル酸エステル系合成吸着剤を試料液から分離除去するものである請求項1~6のいずれかの項記載の微生物検出方法。
- 培養培地に(メタ)アクリル酸エステル系合成吸着剤を作用させるものである請求項1~7のいずれかの項記載の微生物検出方法。
- 培養培地中に(メタ)アクリル酸エステル系合成吸着剤を添加するものである請求項8記載の微生物検出方法。
- 培養培地中の(メタ)アクリル酸エステル系合成吸着剤の含有量が3~20質量%である請求項8又は9記載の微生物検出方法。
- 抗菌活性を有する被験試料が漢方エキス製剤又は生薬である請求項1~10のいずれかの項記載の微生物検出方法。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020167006841A KR102208463B1 (ko) | 2013-08-30 | 2014-06-10 | 미생물 검출 방법 |
US14/766,834 US10059976B2 (en) | 2013-08-30 | 2014-06-10 | Microorganism detection method |
CN201480035372.6A CN105324490B (zh) | 2013-08-30 | 2014-06-10 | 微生物检测方法 |
EP14840357.9A EP3040420B1 (en) | 2013-08-30 | 2014-06-10 | Microorganism detection method |
HK16106365.6A HK1218432A1 (zh) | 2013-08-30 | 2016-06-03 | 微生物檢測方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013179920A JP5975000B2 (ja) | 2013-08-30 | 2013-08-30 | 微生物検出方法 |
JP2013-179920 | 2013-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015029539A1 true WO2015029539A1 (ja) | 2015-03-05 |
Family
ID=52586118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2014/065313 WO2015029539A1 (ja) | 2013-08-30 | 2014-06-10 | 微生物検出方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US10059976B2 (ja) |
EP (1) | EP3040420B1 (ja) |
JP (1) | JP5975000B2 (ja) |
KR (1) | KR102208463B1 (ja) |
CN (1) | CN105324490B (ja) |
HK (1) | HK1218432A1 (ja) |
TW (1) | TWI653337B (ja) |
WO (1) | WO2015029539A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111850089A (zh) * | 2019-04-28 | 2020-10-30 | 成都倍特药业股份有限公司 | 抑菌性β受体激动剂药物的微生物限度检查方法及组合物 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017175999A (ja) * | 2016-03-29 | 2017-10-05 | 株式会社ツムラ | 大建中湯の効果予測方法および投与量決定方法 |
CN107022597A (zh) * | 2017-04-01 | 2017-08-08 | 广西壮族自治区梧州食品药品检验所 | 抗炎胶囊中微生物限度检查方法 |
JP2019201557A (ja) * | 2018-05-21 | 2019-11-28 | Jnc株式会社 | レジオネラ属細菌用培地の製造方法 |
CN109694899A (zh) * | 2019-02-20 | 2019-04-30 | 扬州倍加洁日化有限公司 | 一种含有chg成分的湿巾产品中微生物限度的检测方法 |
CN112103089B (zh) * | 2020-08-17 | 2022-07-12 | 上海大学 | 氮掺杂石墨烯量子点/土元粉基多孔碳复合材料电极、其应用及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06226092A (ja) * | 1993-02-09 | 1994-08-16 | Mitsubishi Kasei Corp | 合成吸着剤の回生方法 |
WO2008038625A1 (fr) | 2006-09-28 | 2008-04-03 | Tsumura & Co. | Milieu de culture de cellules microbiennes et procédé de culture de cellules microbiennes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE885951Q (fr) * | 1977-12-02 | 1981-02-16 | Baylor College Medicine | Resine et procede pour separer des agents antimicrobiens contenus dans les fluides corporels |
SE452336B (sv) * | 1978-06-16 | 1987-11-23 | Boehringer Mannheim Gmbh | Forfarande for pavisning av sjukdomsalstrande mikroorganismer vilka adsorberats extrakorporalt pa en selektivt bindande adsorbent |
US5314855A (en) * | 1992-11-09 | 1994-05-24 | Akzo N.V. | Adsorbent compositions and methods of manufacture |
WO2006130927A1 (en) * | 2005-06-09 | 2006-12-14 | South Australian Water Corporation | Detection of micro-organisms |
AU2010290872B2 (en) * | 2009-09-02 | 2015-06-11 | Piramal Enterprises Limited | Antibiotic compounds |
JP2012152116A (ja) * | 2011-01-24 | 2012-08-16 | Kracie Seiyaku Kk | 生薬の生菌数測定方法 |
-
2013
- 2013-08-30 JP JP2013179920A patent/JP5975000B2/ja active Active
-
2014
- 2014-06-10 CN CN201480035372.6A patent/CN105324490B/zh active Active
- 2014-06-10 KR KR1020167006841A patent/KR102208463B1/ko active IP Right Grant
- 2014-06-10 EP EP14840357.9A patent/EP3040420B1/en active Active
- 2014-06-10 US US14/766,834 patent/US10059976B2/en active Active
- 2014-06-10 WO PCT/JP2014/065313 patent/WO2015029539A1/ja active Application Filing
- 2014-06-24 TW TW103121708A patent/TWI653337B/zh active
-
2016
- 2016-06-03 HK HK16106365.6A patent/HK1218432A1/zh unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06226092A (ja) * | 1993-02-09 | 1994-08-16 | Mitsubishi Kasei Corp | 合成吸着剤の回生方法 |
WO2008038625A1 (fr) | 2006-09-28 | 2008-04-03 | Tsumura & Co. | Milieu de culture de cellules microbiennes et procédé de culture de cellules microbiennes |
Non-Patent Citations (8)
Title |
---|
"General Tests" |
"Kampo Iyakuhin Shu", 2011 |
"Microbial Limit Test for Crude Drugs" |
"Microbial Limit Test in the Japanese Pharmacopoeia" |
"The guide book of the approval standards for OTC Kampo products", 2009, SOCIETY OF JAPANESE PHARMACOPOEIA |
"the Japanese Pharmacopoeia" |
SAIKIA D.M.: "Revisiting adsorption of biomolecules on polymeric resins.", COLLOIDS SURF. A PHYSICOCHEM. ENG. ASP., vol. 315, no. 1-3, 2008, pages 196 - 204, XP022400790 * |
See also references of EP3040420A4 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111850089A (zh) * | 2019-04-28 | 2020-10-30 | 成都倍特药业股份有限公司 | 抑菌性β受体激动剂药物的微生物限度检查方法及组合物 |
Also Published As
Publication number | Publication date |
---|---|
TWI653337B (zh) | 2019-03-11 |
HK1218432A1 (zh) | 2017-02-17 |
CN105324490A (zh) | 2016-02-10 |
KR102208463B1 (ko) | 2021-01-27 |
US20160002697A1 (en) | 2016-01-07 |
US10059976B2 (en) | 2018-08-28 |
EP3040420B1 (en) | 2018-12-19 |
JP2015047106A (ja) | 2015-03-16 |
TW201512403A (zh) | 2015-04-01 |
KR20160048830A (ko) | 2016-05-04 |
JP5975000B2 (ja) | 2016-08-23 |
CN105324490B (zh) | 2020-10-09 |
EP3040420A4 (en) | 2017-04-19 |
EP3040420A1 (en) | 2016-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2015029539A1 (ja) | 微生物検出方法 | |
Ashraf et al. | Chemical composition and biological activities of leaves of Ziziphus mauritiana L. native to Pakistan | |
Anas et al. | In vitro antibacterial activity of Psidium guajava Linn. leaf extract on clinical isolates of multidrug resistant Staphylococcus aureus | |
Biswas et al. | Assessment of cytotoxicity and antibacterial activities of ethanolic extracts of Kalanchoe pinnata Linn.(Family: Crassulaceae) leaves and stems | |
Sevindik | Anticancer, antimicrobial, antioxidant and DNA protective potential of mushroom Leucopaxillus gentianeus (Quél.) Kotl. | |
West et al. | Toxicity and antioxidant tests of Morinda citrifolia (noni) seed extract | |
Ekwenye et al. | Antibacterial activity of Tetrapleura tetraptera Taub. pod extracts | |
Khandekar et al. | Evaluation of antioxident activity, in-vitro antimicrobial activity and phytoconstituents of Schleichera oleosa (Lour.) Oken | |
Gunaga et al. | Antimicrobial and antioxidant activity of Anaphalis lawii (Hook. f.) Gamble | |
GHOSH et al. | Comparative phytochemical analysis of mature mango leaves from nineteen cultivars of Murshidabad district, India | |
Ghosh et al. | Evaluation of the protective effect of Hibiscus sabdariffa L. calyx (Malvaceae) extract on arsenic induced genotoxicity in mice and analysis of its antioxidant properties | |
Batsalova et al. | In vitro cytotoxicity and antioxidative poten-tial of Nostoc microscopicum (Nos-tocales, Cyanobacteria) | |
Aldayel | Potential antibacterial and antioxidant inhibitory activities of Silybum marianum mediated biosynthesised He-Ne laser | |
Mtewa | Antibacterial potency stability, pH and phytochemistry of some Malawian ready-to-serve aqueous herbal formulations used against enteric diseases | |
Islam et al. | In vitro evaluation of Croton bonplandianum Baill. as potential antitumor properties using Agrobacterium tumefaciens | |
CN103301198B (zh) | 一种厚朴全效成分获得方法及其制备方法 | |
Rollando et al. | Bioactive Potential of Cephalosporium sp. a Fungal Endophyte Isolated from Phyllanthus niruri L. | |
Pacana et al. | Antibacterial property of Atuna racemosa Rafin. chrysobalanaceae shell and kernel extracts (aqueous, methanol, ethyl acetate, and decoction) | |
Aly et al. | The antibacterial activity of the traditionally used Cymbopogon schoenanthus and Senna holosericea, collected from Alabwa region, Saudi Arabia | |
Fonseca et al. | Post-production stability of parthenolide in feverfew (Tanacetum parthenium) | |
EROĞLU et al. | In vitro Cytotoxic Effects of methanol extracts of six Helichrysum Taxa used in traditional medicine | |
Lee et al. | Genotoxicity testing of Persicariae Rhizoma (Persicaria tinctoria H. Gross) aqueous extracts | |
Sharma et al. | Phytochemical Screening, In vitro Antioxidant, Antibacterial Activities on Skimmia laureola Leaves Extract: A Research | |
Khati | Mycoflora and aflatoxin assessment of crude herbal drugs during storage in Haridwar, Uttarakhand, India | |
Maharani et al. | The phytochemical composition of medicinal plants in Indonesia and their potential as antibacterial agents against Salmonella typhi ATCC 13311 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201480035372.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14840357 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14766834 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2014840357 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014840357 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20167006841 Country of ref document: KR Kind code of ref document: A |